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Abstract
Background: Secreted phospholipase A2 (sPLA2) is a protein secreted by Clonorchis sinensis and is a component of
excretory and secretory products (CsESPs). Phospholipase A2 is well known for its role in liver fibrosis and inhibition
of tumour cells. The JNK signalling pathway is involved in hepatic stellate cells (HSCs) activation. Blocking JNK
activity with SP600125 inhibits HSCs activation. In a previous study, the protein CssPLA2 was expressed in insoluble
inclusion bodies. Therefore, it’s necessary to express CssPLA2 in water-soluble form and determine whether the
enzymatic activity of CssPLA2 or cell signalling pathways is involved in liver fibrosis caused by clonorchiasis.
Methods: Balb/C mice were given an abdominal injection of MBP-CssPLA2. Liver sections with HE and Masson
staining were observed to detect accumulation of collagen. Western blot of mouse liver was done to detect the
activation of JNK signalling pathway. In vitro, HSCs were incubated with MBP-CssPLA2 to detect the activation of
HSCs as well as the activation of JNK signalling pathway. The mutant of MBP-CssPLA2 without enzymatic activity
was constructed and was also incubated with HSCs to check whether activation of the HSCs was related to the
enzymatic activity of MBP-CssPLA2.
Results: The recombinant protein MBP-CssPLA2 was expressed soluble and of good enzymatic activity. A mutant of
CssPLA2, without enzymatic activity, was also constructed. In vivo liver sections of Balb/C mice that were given an
abdominal injection of 50 μg/ml MBP-CssPLA2 showed an obvious accumulation of collagen and a clear band of
P-JNK1 could be seen by western blot of the liver tissue. In vitro, MBP-CssPLA2, as well as the mutant, was incubated
with HSCs and it was proved that activation of HSCs was related to activation of the JNK signalling pathway instead of
the enzymatic activity of MBP-CssPLA2.
Conclusions: Activation of HSCs by CssPLA2 is related to the activation of the JNK signalling pathway instead of the
enzymatic activity of CssPLA2. This finding could provide a promising treatment strategy to interrupt the process of
liver fibrosis caused by clonorchiasis.
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Background
Clonorchis sinensis is a parasite prevailing mainly in east-
ern countries. In China, northern Vietnam and South
Korea about 15 million people are infected; 13 million in-
fected people come from China alone [1–4]. In 1975, eggs
of C. sinensis were found in a corpse of the Western Han
Dynasty in Hubei province, which showed that the disease
appeared at least two millennia ago [5]. When raw or
undercooked infected fish is eaten by people, the metacer-
caria is excysted by gastric juice from the flesh in the duo-
denum [6]. Cholangitis, cholecystitis and cholelithiasis are
the main complications caused by the chronic infection
with C. sinensis [7–9]. Infiltration of eosinophils and mast
cells, fibrosis and mucosal hyperplasia of the gallbladder
wall are also associated with infection [10]. Infection is
widely considered to be related to cholangiocarcinoma
(CCA). The morbidity of CCA caused by C. sinensis each
year is about 0.035% in males and 0.025% in females [2].
Clonorchis sinensis excretory/secretory products (CsESPs)
is proved to result in liver fibrosis in clonorchiasis. Secreted
phospholipase A2 (sPLA2) is a protein secreted by C.
sinensis and is a component of CsESPs. sPLA2 enzymes,
characterised by low-molecular-weight, calcium-dependent
and a His-Asp catalytic dyad, refer to the largest family
among the phospholipase A2 (PLA2) superfamily [11]. The
parasite lives in the bile duct of the liver and is exposed to
bile which is rich in fatty acid. CssPLA2, which was proved
to be a component of the ESPs of C. sinensis, plays an im-
portant role in the growth of the parasite by breaking down
complex lipids [12, 13]. Liver fibrosis is observed in patients
with moderate or severe infection of liver fluke. Deficiency
of Group IVA phospholipase A2 (IVA-PLA2) alleviates the
deposition of lipids and delays the formation of liver fibro-
sis [14]. CssPLA2 of C. sinensis may lead to liver fibrosis
and HSCs activation which is related to c-Jun N-terminal
kinase (JNK) signalling pathway. When JNK signalling
pathway is blocked by inhibitor SP600125, hepatic stellate
cells (HSCs) activation is inhibited, with less proliferation
and reduced expression of α-smooth muscle actin (α-SMA)
[15]. An increased expression of collagen III has been de-
tected in LX-2 cells by quantitative RT-PCR after incubat-
ing with the recombinant CssPLA2 which was a renatured
protein from inclusion bodies [12]. CssPLA2 was difficult
to express in soluble form and only little insoluble inclusion
bodies renatured by dilution and dialysis were obtained.
Both of cell cycle analysis and MTT test of LX-2 demon-
strated that the percentage of cells in the proliferation
phase was higher [12]. PLA2 from snake venoms have been
widely studied because of the pathophysiological and
pharmacological effects including antiangiogenic and anti-
tumor properties on living organisms [16–18].
To detect the activation of hepatic stellate cells LX-2 as
well as activation of the JNK signalling pathway by the
recombinant protein MBP-CssPLA2, the recombinant
protein MBP-CssPLA2 was expressed in soluble form in
E. coli and displayed the phospholipase activity. MBP-
CssPLA2 could activate hepatic stellate cells which could
lead to liver fibrosis. The mechanism of the hepatic stel-
late cells activation is involved in the activation of JNK sig-
nalling pathway instead of the enzymatic activity of the
protein, which could provide a promising strategy to inter-
rupt the process of liver fibrosis caused by infection of
Clonorchis sinensis.
Methods
Cloning, expression, and purification of the recombinant
protein MBP-CssPLA2
Polymerase chain reaction (PCR) was used to amplify
CDS but not the signal peptide sequence of CssPLA2
gene (GenBank Accession no. DQ974199). The forward
and reverse oligonucleotide primers were: 5′-CTA GTC
TAG AAA ACC ACG GTC AAT TTC A-3′ and 5′-
GGG AAG CTT GCT CAT ACA GTA ATG TAC G-3′
with Xba I and Hind III sites to the 5' ends, respectively
(underlined). Clonorchis sinensis adult cDNA was used
as template. Total RNAs from adult worms were ex-
tracted in Trizol reagent (Invitrogen, Carlsbad, USA)
Amplicons were cloned into pMAL-c2X (New England
Biolabs, Ipswich, USA). The nucleotide sequences of the
recombinant plasmid CssPLA2/pMAL-c2X were con-
firmed by DNA sequencing. The recombinant plasmid
CssPLA2/pMAL-c2X was expressed in E. coli BL21 (DE3)
in Luria-Bertani medium containing 50 μg/ml ampicillin.
The final concentration of 0.3 mM isopropyl-1-thio-galac-
toside (IPTG) was added to induce expression, and the
culture was further incubated at 37 °C for 4 h. The MBP-
CssPLA2 fusion protein was purified by amylose resin
(New England Biolabs, Ipswich, USA) MBP-CssPLA2 was
further purified by anion exchange chromatography with
an anion exchange column (HiTrap Q FF).
SDS-PAGE and western blot
The recombinant protein MBP-CssPLA2 was subjected
to SDS-PAGE (12% polyacrylamide gel) and immobilized
onto polyvinylidenedifluoride membrane. The mem-
brane was incubated with the primary antibodies
(CssPLA2 monoclonal antibody, 1:3000 dilutions in 1%
BSA-PBS) overnight at 4 °C after blocking with 5% skim
milk at room temperature for 2 h. Then the membrane
was washed and incubated with goat anti-mouse IgG
conjugated HRP (1:2000 dilution) (Proteintech, Chicago,
USA) at room temperature for 1 h. The results were vi-
sualized by chemiluminescence (chemiluminescent HRP
substrate, Millipore, Billerica, USA)
Mass spectrometry
The mass spectrometry identification of the recombinant
protein MBP-CssPLA2 was carried out by the Proteomics
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Center, Zhongshan School of Medicine, Sun Yat-sen
University.
Enzyme activity assay
The enzyme activity of CssPLA2 was detected by sPLA2
Assay Kit (Cayman, Ann Arbor, USA). The recombinant
protein MBP-CssPLA2 was dialysed against PBS. Bee
Venom PLA2 was used as the positive and as a negative
control, the MBP protein expressed by empty plasmid
pMAL-c2x was used. 10 μl DTNB, 10 μl sample and 5 μl
assay buffer were added to sample wells. 10 μl DTNB,
10 μl Bee Venom PLA2 and 5 μl assay buffer were added
to positive control wells. Negative control wells contain
10 μl of DTNB, 10 μl of MBP and 5 μl of assay buffer. The
reactions were initiated by adding 200 μl substrate solu-
tion to all the wells. The plate was carefully shaken and
read at an absorbance of 414 nm every 1 min using a mi-
croplate spectrophotometer (SpectraMax M5, American
Molecular Devices, Sunnyvale, USA).
Western blot of mouse liver tissue to detect the
activation of the JNK signalling pathway
Balb/C mice with weights of 18–20 g, 6–8 weeks of age,
male and cared for in a SPF environment were divided
into five groups with three mice in one group, and were
given an abdominal injection of PBS, 100 μg ESPs of
Clonorchis sinensis, 100 μg MBP protein (negative con-
trol), 50 μg of MBP-CsPLA2 protein and 100 μg of
MBP-CssPLA2 protein, respectively, twice a week. The
mice were sacrificed four weeks later and liver sections
with HE and Masson staining were observed for collagen
accumulation. Western blot of the mice liver tissue was
also done to detect the activation of the JNK signalling
pathway related to liver fibrosis.
Construction of MBP-CssPLA2 mutant without enzymatic
activity
The enzymatic center of PLA2 protein is comprised of
two key amino acids, His192 and Asp222. Here, His192
of CssPLA2 was changed into Asn192. Fast mutagenesis
system (Transgen Biotech, Beijing, China) was applied to
deliver the mutation. PCR amplification was performed
with two overlapping primers. Both primers contain the
target mutation. The forward and reverse oligonucleo-
tide primers were: 5′-
CTG ACA TGT GCT GTC GAA CT
AATGACCGATG-3′ and 5′-TAGTTCGACAGCACA
TGT CAG TCT CGA TTT C-3′. PCR was performed
under conditions of the 20 s at 94 °C, 20 s at 57 °C, and
3.5 min at 72 °C for 25 cycles and recombinant plasmid
CssPLA2/pMAL-c2X was used as a template. The differ-
ence between the mutant and MBP-CssPLA2 is only one
amino acid, therefore the expression and purification of
the protein of mutant are the same with that of MBP-
CssPLA2. The enzymatic activity of the mutant is deter-
mined by sPLA2 Assay Kit (Cayman, Ann Arbor, USA).
Detection of collagen I in LX-2 cells incubated with MBP-
CssPLA2 by ELISA
LX-2 cells were cultured in Dulbecco’s modified Eagle
medium (DMEM, Gibco, Carlsbad, USA) with 10% fetal
bovine serum (FBS), penicillin (100 U/ml) and strepto-
mycin (100 μg/ml) at 37 °C under 5% CO2. The effect of
the recombinant MBP-CssPLA2 on the production of col-
lagen I by LX-2 cells was assessed by ELISA. Cells were re-
moved from the cell-culture plastic bottle by trypsin and
seeded into 6-well culture plates (6,000 cells/well, Nest,
Wuxi, China) in the presence of DMEM containing 10%
FBS for 24 h. Diluted in DMEM with 2% FBS, 25 μg/ml
ESPs, 25 μg/ml MBP, 25 μg/ml MBP-CssPLA2 and PBS
were included with cells. After 36 h or 48 h, the super-
natant of cells was detected by ELISA. Collagen I rabbit
antibody (1:2,000 dilutions, Abcam, London, UK) was
used as the first antibody and HRP-conjugated goat anti-
rabbit IgG was used as the secondary antibody (1:10,000
dilutions, Proteintech, Chicago, USA). Each well was incu-
bated with tetramethylbenzidine (TMB) solution. Finally,
the reaction was stopped by 2 M H2SO4, and the absorb-
ance of each well was detected at 450 nm.
Detection of α-SMA in LX-2 cells by Western blotting
The effects of the recombinant MBP-CssPLA2 on LX-2
activation were assessed by Western blot. The expres-
sion of activation markers normalized by β-actin was de-
tected in LX-2, which were divided into three groups
and incubated with 25 μg/ml MBP, 25 μg/ml MBP-
CssPLA2 and PBS, respectively, for 48 h. To further in-
vestigate the dose dependence of MBP-CssPLA2 and the
effect of the JNK inhibitor in the process, LX-2 cells
were then divided into five groups and incubated with
25 μg/ml MBP, 10 μg/ml MBP-CssPLA2, 25 μg/ml
MBP-CssPLA2, PBS and 25 μg/ml MBP-CssPLA2 together
with 5 μM JNK inhibitor (SP600125), respectively, for 48 h.
Then all the cells were lysed by cell lysing buffer and con-
centration of protein was detected by bicinchoninic acid
(BCA) protein assay kit (Novagen, Darmstadt, Germany).
The recombinant protein MBP-CssPLA2 was subjected to
SDS-PAGE (12% polyacrylamide gel) and immobilized
onto a polyvinylidenedifluoride membrane. The membrane
was incubated with the primary antibodies (α-SMA anti-
body, 1:500 dilutions in 1% BSA-PBS) (Proteintech,
Chicago, USA) overnight at 4 °C after blocking with 5%
skim milk at room temperature for 2 h. Then the mem-
brane was washed and incubated with goat anti-rabbit
immunoglobulin G conjugated HRP (1:5,000 dilution)
(Proteintech, Chicago, USA) at room temperature for 1 h.
The results were visualized by chemiluminescence (chemi-
luminescent HRP substrate, Milipore, Billerica, USA).
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Quantitative RT-PCR analysis of activation markers of LX-2
LX-2 cells were incubated with 25 μg/ml MBP-CssPLA2,
25 μg/ml mutant and 25 μg/ml MBP-CssPLA2 together
with 5 μM JNK inhibitor (SP600125), respectively, for
24 h. Total RNA was extracted from LX-2 cells using
Trizol. One microgram of total RNA was reverse tran-
scribed into cDNA with the reverse transcriptase kit
(Takara, Dalian, China). Using SYBR Premix ExTaq,
cDNA was used as the template for PCR amplification.
The primers of human smooth muscle actin (α-SMA)
were 5′-CCA GGG CTG TTT TCC CAT CC-3′ (for-
ward primer) and 5′-GCT CTG TGC TTC GTC
ACC CA-3′ (reverse primer). The primers of human
collagen III were 5′-GGT CCT CCT GGA ACT GCC
GGA-3′ (forward primer) and 5′-GAG GAC CTT
GAG CAC CAG CGT GT-3′ (reverse primer). The
primers of human β-actin were 5′-GTC CAC CGC
AAA TGC TTC TA-3′ (forward primer) and 5′-T
GC TCT CAC CTT CAC CGT TC-3′ (reverse primer).
The human β-actin served as the internal standard.
PCR conditions were as follows: 95 °C for 30 s, 40 cy-
cles of 95 °C for 5 s, and 60 °C for 20 s, with an in-
cremental increase of 0.1 °C/s from 60 to 95 °C.
Detection of P-JNK1 in LX-2 cells incubated with MBP-
CssPLA2 and the mutant respectively by Western blotting
The effects of the recombinant MBP-CssPLA2 and the
mutant on JNK signalling activation in LX-2 cells was
assessed by Western blot. LX-2 cells were incubated for
48 h with 25 μg/ml MBP, 25 μg/ml MBP-CssPLA2, 25 μg/
ml mutant and PBS, respectively. The expression of
phospho-JNK1 was detected and normalized by β-actin in
LX-2 cells. Then all the cells were lysed by cell lysing buf-
fer and concentration of protein was detected by bicincho-
ninic acid (BCA) protein assay kit (Novagen). The protein
was subjected to SDS-PAGE (12% polyacrylamide gel) and
immobilized onto a polyvinylidenedifluoride membrane.
The membrane was incubated with the primary antibodies
(P-JNK1 antibody, 1:1000 dilutions in 1% BSA-PBS) (CST,
Boston, USA) overnight at 4 °C after blocking with 5%
skim milk at room temperature for 2 h. Then the mem-
brane was washed and incubated with goat anti-rabbit im-
munoglobulin G conjugated HRP (1:5000 dilution)
(Proteintech, Chicago, USA) at room temperature for 1 h.
The results were visualized by chemiluminescence (chemi-
luminescent HRP substrate, Millipore, Billerica, USA)).
Statistical analysis
Results were analyzed by the software GraphPad Prism 5
using the method t-test to compare the difference be-
tween the experimental group and the control group,
considering values of P < 0.05 as significant.
Results
Prokaryotic expression and purification of MBP-CssPLA2
The length of PCR product of CssPLA2 was 828 bp
(Fig. 1a). The soluble MBP-CssPLA2 was expressed with
a MBP tag in E. coli BL21 (DE3) after being induced
with 0.3 mM IPTG at 37 °C for 4 h. The recombinant
protein was purified by amylose resin (Fig. 1b) and anion
exchange chromatography (Fig. 1c). The purified MBP
fusion protein showed a single band with a molecular
mass around 76 kDa in 12% SDS-PAGE, consistent with
the predicted molecular mass (Fig. 1d). The protein
MBP-CssPLA2 was identified by both western blot with
the CssPLA2 monoclonal antibody (Fig. 2a) and mass
spectrometry (Fig. 2b). The final protein concentration
was 0.5 mg/ml while the concentration of endotoxin-
free MBP-CsPLA2 was about 0.2 mg/ml.
Enzymatic activity of MBP-CssPLA2
The enzymatic activity of MBP-CssPLA2 was detected
with sPLA2 Assay Kit, it showed good enzymatic activity
with protein MBP as a negative control and bee venom
sPLA2 as a positive control (Fig. 3a). The enzyme was
heat resistant and showed good enzymatic activity at
50 °C (Fig. 3b). The enzymatic activity got better with ei-
ther higher concentration of enzyme or higher concen-
tration of substrate until an optimum concentration was
obtained. (Fig. 3c, d).
Liver fibrosis and activation of the JNK signalling pathway
by MBP-CssPLA2 in liver tissue of Balb/C mouse
Liver sections of five groups of Balb/C mice with
hematoxylin/eosin (HE) and Masson staining were ob-
served under a microscope. Collagen was stained blue in
liver sections with Masson staining. The group of mice
given an abdominal injection of 50 μg MBP-CssPLA2
showed obvious collagen accumulation compared with
other groups (Fig. 4a). Western blot of the liver tissue of
the five groups of mice was also done to detect whether
JNK signalling pathway was activated. Consistent with
the result of liver sections with Masson staining, the
group of mice given an abdominal injection of 50 μg
MBP-CssPLA2 showed activation of JNK signalling path-
way and a clear band of P-JNK1 can be observed
(Fig. 4b). Relative quantitative western blot analysis of P-
JNK1 was performed to compare the difference between
experimental group and control group (AlphaView
Software was used to adjust the gray level of western
blot image). Figure 4c provides an illustration of three
independent experiments. Unpaired t-tests revealed sig-
nificant differences between the group injected with
50 μg MBP-CssPLA2 and the group injected with
100 μg MBP (t(4) = 3.298, P = 0.03).
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Construction of MBP-CssPLA2 mutant
PCR amplification with the plasmid CssPLA2/pMAL-
c2X as a template was done to obtain the plasmid of the
mutant (Fig. 5a). The mutant protein lost the enzymatic
activity (Fig. 5b). The nucleotide sequences of the plas-
mid of the mutant were confirmed by DNA sequencing
(Fig. 5c, d).
JNK signalling pathway is involved in activation of LX-2
cells by MBP-CssPLA2
The effect of MBP-CssPLA2 on activation of hepatic
stellate cells and production of collagen I was evaluated
by ELISA. Either after 36 h (Fig. 6a) or 48 h (Fig. 6b), the
group of cells incubated with 25 μg/ml MBP-CssPLA2
showed the largest amount of collagen I in the super-
natant of cell culture. Figure 6 provides an illustration of
three independent experiments. Unpaired t-tests revealed
significant differences between the group incubated
with 25 μg/ml MBP-CssPLA2 and the group incubated
with 25 μg/ml MBP (t(4) = 5.02, P = 0.0074) (Fig. 6a) and
(t(4) = 8.78, P = 0.0009) (Fig. 6b).
Western blot was also done to detect the activation of
hepatic stellate cells. The marker of the activation, α-
SMA of the hepatic stellate cells, was measured after in-
cubated with 25 μg/ml MBP, 25 μg/ml MBP-CssPLA2
and PBS respectively. The hepatic stellate cells incubated
with 25 μg/ml MBP-CssPLA2 showed a clear band of
α-SMA (Fig. 7a).
To detect whether the activation of hepatic stellate cells
by MBP-CssPLA2 was dose-dependent and whether the
activation was related to activation of JNK signalling path-
way, two more groups, the group of cells incubated with
10 μg/ml MBP-CssPLA2 and the group of cells incubated
with both 25 μg/ml MBP-CssPLA2 and 5 μM JNK inhibi-
tor (SP600125) were added. Western blot was done again
and MBP-CssPLA2 showed a dose-dependent effect on
Fig. 1 Prokaryotic expression and purification of protein CssPLA2 with plasmid pMAL-c2X. a PCR product of CssPLA2 (828 bp). Lane M: DNA
molecular marker; Lane 1: ddH2O negative control; Lane 2: PCR product of CssPLA2 (828 bp). b SDS-PAGE analysis of the prokaryotic expression
product of CssPLA2. Lane M: protein molecular weight marker; Lane 1: CssPLA2/pMAL-c2X transformants without IPTG induction; Lane 2: supernatant
of the lysate of bacteria with CssPLA2/pMAL-c2X after IPTG induction; Lane 3: precipitation of the lysate of bacteria with CssPLA2/pMAL-c2X after IPTG
induction; Lane 4: purified MBP-CssPLA2 protein. c Anion exchange chromatography for purification of MBP-CssPLA2 protein. d SDS-PAGE analysis of
MBP-CssPLA2 protein after anion exchange chromatography. Lane M: protein molecular weight marker; Lane 1: MBP-CssPLA2 protein purified by
amylose resin; Lane 2: MBP-CssPLA2 protein purified by amylose resin and anion exchange chromatography
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Fig. 2 Identification of protein MBP-CssPLA2 by western blot and mass spectrum. a The recombinant protein MBP-CssPLA2 was identified by
western blot with CssPLA2 monoclonal antibody. CssPLA2 monoclonal antibody (1:3,000 dilution) was used as first antibody and goat anti-mouse
immunoglobulin G conjugated HRP (1:2000 dilution) was used as the second antibody. Lane 1: the recombinant protein MBP-CssPLA2; Lane 2:
protein MBP. b The recombinant protein MBP-CssPLA2 was identified by mass spectrometry
Fig. 3 Detection of the enzymatic activity of MBP-CssPLA2. The enzyme activity of CssPLA2 was detected by sPLA2 Assay Kit. Bee venom PLA2
was used as positive controls and the MBP protein expressed by empty plasmid pMAL-c2X was used as negative control. a Detection of enzymatic
activity of MBP-CssPLA2. b Influence of the temperature on the enzymatic activity of MBP-CssPLA2. c Influence of enzyme concentration to enzymatic
activity of MBP-CssPLA2. d Influence of the substrate concentration on the enzymatic activity of MBP-CssPLA2
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activation of hepatic stellate cells as well as relation with
activation of the JNK signalling pathway (Fig. 7b). Relative
quantitative western blot analysis of α-SMA was per-
formed to compare the difference between experimental
group and control group. Figure 7c provides an illustra-
tion of three independent experiments. Unpaired t-tests
revealed significant differences between the group incu-
bated with 25 μg/ml MBP-CssPLA2 and the group incu-
bated with 25 μg/ml MBP (t(2) = 23.63, P = 0.0018),
between the group incubated with 25 μg/ml MBP-
CssPLA2 and the group incubated with 25 μg/ml MBP-
CssPLA2 + 5 μM JNK inhibitor (t(2) = 64.77, P = 0.0002).
To determine whether the activation of hepatic stellate
cells by MBP-CssPLA2 was related to the enzymatic ac-
tivity of the protein or not, the hepatic stellate cells were
divided into three groups and incubated with 25 μg/ml
mutant, 25 μg/ml MBP-CssPLA2, and 25 μg/ml MBP-
CssPLA2 + 5 μM JNK inhibitor (SP600125), respectively.
Quantitative RT-PCR analysis of activation markers of
LX-2 was performed. The mRNA of α –SMA and collagen
III were detected, and the difference between the group
incubated with the mutant and the group incubated with
MBP-CssPLA2 was of no statistical significance, while the
difference between the group incubated with MBP-
CssPLA2 and the group incubated with both 25 μg/ml
MBP-CssPLA2 and 5 μM JNK inhibitor (SP600125) was
significant: t(4) =3.905, P = 0.0175 (Fig. 8a) and t(4) = 4.095,
P = 0.0149 (Fig. 8b). Unpaired t-test was applied and the
difference between the group incubated with the mutant
and the group incubated with MBP-CssPLA2 was of no
statistical significance.
Western blot was done to detect the activation of JNK
signalling in HSCs incubated with MBP-CssPLA2 and
the mutant. The marker of activation, phospho-JNK1 of
HSCs, was measured after incubated with 25 μg/ml
MBP, 25 μg/ml MBP-CssPLA2, 25 μg/ml mutant and
Fig. 4 JNK signalling was activated in the liver tissue of Balb/C mouse with abdominal injection of MBP-CssPLA2. a Liver sections of five groups
of Balb/C mouse with HE and Masson staining. Sections 1 & 2, HE and MASSON staining of liver sections of Balb/C mouse with an abdominal injection
of PBS; Sections 3 & 4, HE and MASSON staining of liver sections of Balb/C mouse with an abdominal injection of 100 μg ESPs; Sections 5 & 6, HE and
MASSON staining of liver sections of Balb/C mouse with an abdominal injection of 100 μg MBP; Sections 7 & 8: HE and MASSON staining of liver
sections of Balb/C mouse with an abdominal injection of 50 μg MBP-CssPLA2; Sections 9 & 10, HE and MASSON staining of liver sections of Balb/C
mouse with an abdominal injection of 100 μg MBP-CssPLA2; b Western blot of liver tissue of five groups of Balb/C mouse with P-JNK1 monoclonal
antibody. Lane 1: Liver tissue of Balb/C mouse with an abdominal injection of PBS; Lane 2: Liver tissue of Balb/C mouse with an abdominal injection of
100 μg ESPs; Lane 3: Liver tissue of Balb/C mouse with an abdominal injection of 100 μg MBP; Lane 4: Liver tissue of Balb/C mouse with an abdominal
injection of 50 μg MBP-CssPLA2; Lane 5: Liver tissue of Balb/C mouse with an abdominal injection of 100 μg MBP-CssPLA2. c Quantitative western blot
analysis of P-JNK1. Unpaired t-test was applied for statistical analysis. Compared with control group, JNK signalling of experimental group, the liver
tissue of Balb/C mouse with an abdominal injection of 50 μg MBP-CssPLA2 was activated (t(4) = 3.298, P = 0.03)
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Fig. 5 Construction of mutant of MBP-CssPLA2 without enzymatic activity. a PCR product of the plasmid of the mutant. Lane M: DNA molecular
marker; Lane 1: ddH2O negative control; Lane 2: PCR product of mutant of MBP-CssPLA2. b Detection of enzymatic activity of the mutant. c
Sequence of the mutant plasmid of CssPLA2/pMAL-c2X. d Sequence of the plasmid of CssPLA2/pMAL-c2X
Fig. 6 Collagen I produced by HSCs are increased after incubated with MBP-CssPLA2. The effect of MBP-CssPLA2 on activation of hepatic stellate
cells and production of collagen I was evaluated by ELISA. After 36 h or 48 h, the supernatant of cells was detected by ELISA. Collagen I rabbit
antibody (1:2000 dilutions) was used as the first antibody and HRP-conjugated goat anti-rabbit IgG was used as a secondary antibody (1:10,000
dilution). a Supernatant of cell culture after incubation for 36 h; b supernatant of cell culture after incubation for 48 h. Unpaired t-test was applied
for statistical analysis
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PBS, respectively. Both HSCs incubated with 25 μg/ml
MBP-CssPLA2 and that incubated with 25 μg/ml mutant
showed a clear band for P-JNK1 (Fig. 9a). Relative quan-
titative western blot analysis of P-JNK1 was performed
to compare the difference between experimental group
and control group. Figure 9b provides an illustration of
three independent experiments. Unpaired t-tests re-
vealed significant differences between the group incu-
bated with 25 μg/ml MBP-CssPLA2 and the group
incubated with 25 μg/ml MBP (t(4) = 4.899, P = 0.008),
between the group incubated with 25 μg/ml mutant
and the group incubated with 25 μg/ml MBP (t(4) = 3.605,
P = 0.0227).
Discussion
ESPs are continuously released by adult C. sinensis and
contribute to interactions between the parasite and the
host [19]. sPLA2 is a protein secreted by C. sinensis and
is a component of CsESPs. After incubated with CsESPs
for 24 h, LX-2 cells could be activated. It’s proved that
CsESPs play an important role in liver fibrosis caused by
clonorchiasis. Cell proliferation was detected by methyl
thiazolyltetrazolium (MTT) assay when LX-2 cells were
incubated with 50 μg/ml of CsESPs [20]. The phospho-
lipase A2 has been well known for its function in liver fi-
brosis and inhibition of tumor cells. It’s suggested by the
present findings that ASB14780, an IVA-PLA2 inhibitor,
could be effective for the treatment of hepatic fibrosis
[21]. PLA2 is an abundant component of snake venom.
Bothropstoxin-I, a Lys49-phospholipase A2, which from
Bothrops jararacussu venom was proved to cause cell
death for both human and murine tumor cell lines by in-
ducing apoptosis or necrosis [22]. In the present study,
we have expressed the recombinant protein MBP-
CssPLA2, which is water-soluble with good enzymatic
activity. Balb/C mice were given an abdominal injection
of MBP-CssPLA2 to detect whether the protein could
activate hepatic stellate cells in vivo, and cause accumu-
lation of collagen which leads to liver fibrosis. Hepatic
stellate cells were also incubated with the protein MBP-
CssPLA2 to detect the activation of the cells in vitro. It
was proved that MBP-CssPLA2 could activate hepatic
stellate cells and cause accumulation of collagen both in
vivo and in vitro. This result was in accordance with the
finding that the deficiency of mouse PLA2 could attenuate
hepatic fibrosis formation [14]. The mutant without en-
zymatic activity was constructed to investigate the mechan-
ism of activation of HSCs by MBP-CssPLA2, while it was
found that activation of HSCs was not related to the en-
zymatic activity of the protein. To clarify whether JNK sig-
nalling pathway is involved and activated during the
process, JNK inhibitor (SP600125) was applied. SP600125
is a broad spectrum JNK inhibitor for JNK1, JNK2 and
JNK3 with IC50 of 40 nM, 40 nM and 90 nM, respectively;
10-fold greater selectivity against MKK4, 25-fold greater se-
lectivity against MKK3, MKK6, PKB, and PKCα, and 100-
fold selectivity against ERK2, p38, Chk1, GFR etc. In cell
free assay, IC50 value is 40/40/90 nM (JNK1/2/3). How-
ever, in a cell based assay, the recommended concentration
of SP600125 is 5–10 μM. In Jurkat T cells, SP600125
Fig. 7 HSCs are activated after incubated with MBP-CssPLA2. The
marker of the activation, α-SMA of the HSCs, was measured after
incubated with 25 μg/ml MBP, 25 μg/ml MBP-CssPLA2 and PBS,
respectively. Two more groups, the group of cells incubated with
10 μg/ml MBP-CssPLA2 and the group of cells incubated with both
25 μg/ml MBP-CssPLA2 and 5 μM JNK inhibitor (SP600125) were
added to detect whether the activation of hepatic stellate cells by
MBP-CssPLA2 was dose-dependent and whether the activation was
related to activation of the JNK signalling pathway. a Lane 1: HSCs
incubated with 25 μg/ml MBP; Lane 2: HSCs incubated with 25
μg/ml MBP-CssPLA2; Lane 3: HSCs incubated with PBS. b Lane 1:
HSCs incubated with 25 μg/ml MBP; Lane 2: HSCs incubated with
10 μg/ml MBP-CssPLA2; Lane 3: HSCs incubated with 25 μg/ml
MBP-CssPLA2; Lane 4: HSCs incubated with PBS; Lane 5: HSCs
incubated with both 25 μg/ml MBP-CssPLA2 and 5 μM JNK inhibitor
(SP600125). c Relative quantitative western blot analysis of α-SMA was
performed to compare the difference between experimental group
and control group. Statistical analysis were conducted with
unpaired t-test
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inhibits the phosphorylation of c-Jun with IC50 of 5 μM to
10 μM [23]. It was found that JNK signalling pathway acti-
vation had activated the hepatic stellate cells. Western blot
showed that both MBP-CssPLA2 and the mutant could
activate JNK signalling.
The spatial structure of CssPLA2 is complex. Therefore,
it was difficult to express the protein in water-soluble
form with enzymatic activity. The recombinant protein
CssPLA2 was expressed by pET-28a vector as insoluble
inclusion bodies and renatured by dilution and dialysis
[12]. We also tried other prokaryotic vectors, such as
pET-30a, pET-26b, pET-32a and pGEX-4T-1, but all
the products were inclusion bodies, without enzymatic
activity. Finally, the vector pMAL-c2X was chosen and
water-soluble protein was expressed with good enzymatic
activity. pMAL-c2X is a prokaryotic vector with a MBP
(maltose binding protein) tag, which can promote the
solubility of proteins. Either GST or TRX can be used for
soluble expression of protein, while the MBP is much
more effective [24, 25].
The sn-2 ester bond of phospholipids is hydrolysed by
phospholipase A2 enzyme through a nucleophile water
molecule and catalytic histidine. The histidine conform-
ation is critical for PLA2 to hydrolyse the phospholipids
[13]. The protein itself is an enzyme, and therefore, there
are two ways for it to work. It works by its enzymatic ac-
tivity or by activating the cell signalling pathway. The
construction of a mutant was to identify which way the
protein works. The mutant was the same as the protein
MBP-CssPLA2 except for one amino acid difference.
The 192nd amino acid of the mutant is asparagine in-
stead of histidine, which is the most important amino
acid related to the catalytic ability of the enzyme. The
pathogenesis of liver fibrosis involves extracellular
matrix protein deposition, including collagen I and colla-
gen III, and requires activation of HSCs. JNK signalling
pathway is related to HSCs activation. When JNK activ-
ity was blocked by the inhibitor SP600125, HSCs activity
was inhibited, with reduced proliferation and less ex-
pression of α-smooth muscle actin (α-SMA) [15].
Liver fibrosis, a worldwide medical problem charac-
terised by excessive deposition of extracellular matrix
(ECM) proteins, is a scarring process caused by chronic
liver injury [26, 27]. The predominant hepatic cells in
the liver tissue contributing to excessive ECM deposition
are HSCs [28]. As a stable and an unlimited source of
human HSCs, LX-2 cell line is widely used for studying
human liver fibrosis [29]. When quiescent HSCs are
stimulated by liver insults, the lipid droplets are lost and
a new myofibroblastic phenotype is obtained, with
Fig. 8 HSCs are activated after incubated with either MBP-CssPLA2 or the mutant. Quantitative RT-PCR analysis of activation markers of LX-2 was
performed. The mRNA of α-SMA and collagen III were detected, respectively. The transcription levels of α -SMA and collagen III were analyzed by
means of the 2-△△Ct ratio, with human β-actin serving as the internal standard. The transcription level of α-SMA and collagen III in LX-2 cells incubated
with 25 μg/ml mutant and 25 μg/ml MBP-CssPLA2 was similar, with no statistical significance, while that of LX-2 cells incubated with both 25 μg/ml
MBP-CssPLA2 and 5 μM JNK inhibitor (SP600125) was lower than that of cells incubated with 25 μg/ml MBP-CssPLA2. Unpaired t-test was applied
to compare the difference between experimental group and control group. a The relative levels of mRNA for α-SMA of three groups of LX-2 cells
incubated with 25 μg/ml mutant, 25 μg/ml MBP-CssPLA2 and both 25 μg/ml MBP-CssPLA2 and 5 μM JNK inhibitor (SP600125), respectively (t(4) = 3.905,
P= 0.0175). b Relative levels of mRNA for collagen III of three groups of LX-2 cells incubated with 25 μg/ml mutant, 25 μg/ml MBP-CssPLA2 and both
25 μg/ml MBP-CssPLA2 and 5 μM JNK inhibitor (SP600125), respectively (t(4) = 4.095, P= 0.0149)
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increased expression of ECM proteins and α-SMA [30].
The LX-2 cells were activated by the recombinant pro-
tein MBP-CssPLA2 both in vitro and in vivo.
Conclusions
CssPLA2, as one component of CsESPs, can activate
HSCs resulting in accumulation of collagen in vivo,
which could be the reason of liver fibrosis and it can in-
crease the level of a-SMA in hepatic stellate cells in a
dose-dependent manner in vitro, which is the character-
istic of activation of HSCs. The activation of hepatic stel-
late cells by CssPLA2 is related to activation of the JNK
signalling pathway instead of the enzymatic activity of
the protein, which could provide a promising strategy to
interrupt the process of liver fibrosis caused by infection
of Clonorchis sinensis.
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